Abstract
Chagas disease (CD) is an emergent disease in Europe that can behave as an opportunistic infection in HIV positive patients. The objective of this study was to evaluate the implementation of a CD screening programme in an HIV unit. An immunochromatography (ICT) of Trypanosoma cruzi was performed as a screening tool in HIV-positive patients born in CD endemic countries. ELISA and IFAT were used to confirm the diagnosis. A total of 155 patients, 116 males and 38 females, were included. Mean age was 36.9 years (±8.4) and mean length of stay in Spain at the screening was 7.1 years (±4.7). T. cruzi ICT was positive in four cases (2.6%), being confirmed (by ELISA and IFAT) in three of those (1.9%). Factors associated with confirmed positive T.cruzi serology were: Bolivia origin (p = 0.016), Bolivia or Argentina origin (p = 0.002), Southern Cone origin (p = 0.015), rural origin (p = 0.023), previously living in an adobe-made (p = 0.001) or thatch-roofed house (p < 0.0001), having a previous CD test (p = 0.015), previous knowledge about CD (p = 0.019), about vector (p = 0.009) or recorded seeing vectors at home (p = 0.012). Units dealing with HIV patients from endemic areas of American trypanosomiasis should implement CD screening protocols. Interviews of patients coming from endemic areas should include CD epidemiological questions.
Similar content being viewed by others
References
Pan American Health Organization (2006) Quantitative estimation of Chags disease in the Americas. Montevideo, Uruguay, pp 1–28. http://www.bvsops.org.uy/pdf/chagas19.pdf. Accessed 11 July 2011
Schmunis GA, Yadon ZE (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115:14–21
Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49:e52–e54
WHO (2010) Control and prevention of Chagas disease in Europe. Report of a WHO informal consultation (jointly organized by WHO headquarters and the WHO Regional Office for Europe). World Health Organization, Geneva, Switzerland, 17–18 December 2009
Kirchhoff L (2006) American Trypanosomiasis (Chagas’ disease). In: Guerrant R, Walker D, Weller P (eds) Tropical infectious diseases: principles, pathogens, & practice. Elsevier, Philadelphia, pp 1082–1094
No authors listed (2006) Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection. Rev Soc Bras Med Trop 39:392–415 [Article in Portuguese]
Sartori AM, Ibrahim KY, Nunes Westphalen EV, Braz LM, Oliveira OC Jr, Gakiya E et al (2007) Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 101:31–50
Albrecht H (1997) Redefining AIDS: towards a modification of the current AIDS case definition. Clin Infect Dis 24:64–74
Sartori AM, Shikanai-Yasuda MA, Amato Neto V, Lopes MH (1998) Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clin Infect Dis 26:177–179
Sartori AM, Neto JE, Nunes EV, Braz LM, Caiaffa-Filho HH, Oliveira Oda C Jr et al (2002) Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis 186:872–875
Panel de expertos de Grupo de Estudio del Sida, Plan Nacional sobre el Sida (2008) Prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan AIDS Study Group (GESIDA) and National AIDS Plan. Enferm Infecc Microbiol Clin 26:437–464, [Article in Spanish]
Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H et al (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58:1–207, quiz CE1-4
Panel de expertos de GESIDA, Plan Nacional sobre el Sida (2011) [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)]. Enferm Infecc Microbiol Clin 29:209 e1–e103
European AIDS Clinical Society (2011) Clinical management and treatment of HIV-infected adults in Europe. http://www.europeanaidsclinicalsociety.org/guid/index.html?ml=1. Accesed 10 July 2011
Rodriguez-Guardado A, Alvarez VA, Rodriguez Perez M, Alvarez PM, Flores-Chavez M, Gonzalez PA et al (2011) Screening for Chagas' disease in HIV-positive immigrants from endemic areas. Epidemiol Infect 139:539–543
Almeida EA, Lima JN, Lages-Silva E, Guariento ME, Aoki FH, Torres-Morales AE et al (2010) Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg 104:447–452
Rodriguez-Guardado A, Rodriguez M, Alonso P, Seco C, Flores-Chavez M, Mejuto P et al (2009) Serological screening of Chagas disease in an immigrant population in Asturias, Spain proceeding from Chagas-endemic areas. Scand J Infect Dis 41:774–776
Jackson Y, Getaz L, Wolff H, Holst M, Mauris A, Tardin A et al (2010) Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis 4:e592
Soriano Arandes A, Munoz Gutierrez J, Verges Navarro M, Castells Domenech C, Portus Vinyeta M, Gascon Brustenga J (2009) Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain). Acta Trop 112:228–230
Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD (2007) The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health 9:43–47
Kirchhoff LV, Gam AA, Gilliam FC (1987) American trypanosomiasis (Chagas' disease) in Central American immigrants. Am J Med 82:915–920
Pérez-Ayala A, Pérez-Molina JA, Norman F, Navarro M, Monge-Maillo B, Díaz-Menéndez M et al (2010) Chagas disease in Latin American migrants: a Spanish challenge. Clin Microbiol Infect. doi:10.1111/j.1469-0691.2010.03423.x
Manzardo C, Treviño B, Gómez i Prat J, Cabezos J, Monguí E, Clavería I et al (2008) Communicable diseases in the immigrant population attended to in a tropical medicine unit: Epidemiological aspects and public health issues. Trav Med Infect Dis 6:4–11
Muñoz J, Coll O, Juncosa T, Vergés M, del Pino M, Fumado V et al (2009) Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis 48:1736–1740
Lucas RM, Barba MC (2009) Prevalencia de tripanomiasis americana en mujeres gestantes de un area de salud: Valencia, 2005–2007. Rev Esp Salud Publica 83:543–555
Ramos JM, Milla A, Sanchez V, Verges M, Toro C, Gutierrez F (2009) Cribado prenatal de la infeccion por Trypanosoma cruzi y virus linfotropico humano de celulas T en gestantes latinoamericanas. Enferm Infecc Microbiol Clin 27:165–167
Paricio-Talayero JM, Benlloch-Muncharaz MJ, Collar-del-Castillo JI, Rubio-Soriano A, Serrat-Perez C, Magraner-Egea J et al (2008) Vigilancia epidemiologica de la transmision vertical de la enfermedad de Chagas en tres maternidades de la Comunidad Valenciana. Enferm Infecc Microbiol Clin 26:609–613
Gonzalez-Granado LI, Rojo-Conejo P, Ruiz-Contreras J, Gonzalez-Tome MI (2009) Chagas disease travels to Europe. Lancet 373:2025
Scapellato PG, Bottaro EG, Rodríguez-Brieschke MT (2009) Mother-child transmission of Chagas disease: could coinfection with human immunodeficiency virus increase the risk? Rev Soc Bras Med Trop 42:107–109
Piron M, Verges M, Munoz J, Casamitjana N, Sanz S, Maymo RM et al (2008) Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 48:1862–1868
Schmunis GA (2007) Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102(Suppl 1):75–85
Flores-Chavez M, Cruz I, Rodriguez M, Nieto J, Franco E, Garate T et al (2010) Comparación de técnicas serológicas convencionales y no convencionales para el diagnóstico de la enfermedad de Chagas importada en España. Enferm Infecc Microbiol Clin 28:284–293
Lopez-Chejade P, Roca C, Posada E, Pinazo MJ, Gascon J, Portus M (2010) Utilidad de un test inmunocromatografico para el cribado de la enfermedad de Chagas en asistencia primaria. Enferm Infecc Microbiol Clin 28:169–171
Ponce C, Ponce E, Vinelli E, Montoya A, de Aguilar V, Gonzalez A et al (2005) Validation of a rapid and reliable test for diagnosis of Chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America. J Clin Microbiol 43:5065–5068
Luquetti AO, Ponce C, Ponce E, Esfandiari J, Schijman A, Revollo S et al (2003) Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. Diagn Microbiol Infect Dis 46:265–271
Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N et al (2008) Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood. J Clin Microbiol 46:2022–2027
Acknowledgement
We would like to acknowledge the support and collaboration of the personnel of the Centro Nacional de Microbiología-Instituto de Salud Carlos III, who carried out the ELISA, IFAT and PCR techniques. This study was conducted with the financial support of the European University of Madrid. This study was performed under the Río Hortega Research Educational Contract from the Instituto de Salud Carlos III to J.L.G.
Conflict of interest
All authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Llenas-García, J., Hernando, A., Fiorante, S. et al. Chagas disease screening among HIV-positive Latin American immigrants: an emerging problem. Eur J Clin Microbiol Infect Dis 31, 1991–1997 (2012). https://doi.org/10.1007/s10096-011-1531-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-011-1531-4